EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria

Cagdas Boyvadoglu iD, Hasan Ulusal iD, Seyithan Taysı iD, Goknur Ozaydin-Yavuz iD, Ibrahim Halil Yavuz iD, Pınar Korkmaz iD, Huseyin Serhat Inaloz iD

Mediators of Inflammation · 26.09.2023 · 2023 · 1-6

DOI: 10.1155/2023/8087274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mediators of Inflammation, erschienen am 26.09.2023. Verfasst von Cagdas Boyvadoglu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Ceyhan State Hospital, Adana, Turkey. Hauptthemen laut MEDLINE: Anti-Allergic Agents, Chronic Urticaria, Urticaria. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gaziantep Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanism of action of omalizumab in urticaria is still not literally known. This study examines the serum values of substance P (SP), calcitonin gene-related peptide (CGRP), neuropeptide Y (NPY), and interleukin-31 (IL-31) in patients using omalizumab. In this study, 30 patients with chronic spontaneous urticaria (CSU) who were going to be treated with omalizumab and 20 healthy volunteers took part. Demographic data, clinical data, and disease activity scores were noted. For serum SP, CGRP, NPY, and IL-31 values, 10 mL of blood were taken from the patients before starting the treatment, 3 months after the treatment, at the end of the 6th month, and from healthy volunteers all at once. The change in values measured at baseline, 3rd month, and 6th month was analyzed by the Friedman Test. The Mann–Whitney U test was used to compare the parameters obtained from the patients and control groups. The significance level was set at p = 0.05 . SP, CGRP, NPY, and IL-31 values were all statistically significantly lower in the CSU patient group compared to the control group. After treatment, the levels of SP and CGRP in the serum went up, and the levels of serum IL-31 went down. These changes were statistically significant. This study supports the view that omalizumab does not only affect IgE receptors but also affects mast cells through other mechanisms. According to our knowledge, this is the first study to show that omalizumab therapy and serum CGRP levels are related.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Allergic AgentsChronic UrticariaUrticariaHumansOmalizumabCalcitonin Gene-Related PeptideNeuropeptide YSubstance PImmunoglobulin ETreatment OutcomeInterleukinsChronic Disease

Substanzen

OmalizumabCalcitonin Gene-Related PeptideNeuropeptide YSubstance PAnti-Allergic AgentsImmunoglobulin EInterleukins

Autor:innen und Institutionen

  • Department of Dermatology, Ceyhan State Hospital, Adana, Turkey.
  • Department of Medical Biochemistry, University of Gaziantep Faculty of Medicine, Gaziantep, Turkey.
  • Department of Dermatology, Yuzuncu Yil University Faculty of Medicine, Van, Turkey.
  • Department of Dermatology, Ersin Arslan Training and Research Hospital, Gaziantep, Turkey.
  • Department of Dermatology, University of Gaziantep Faculty of Medicine, Gaziantep, Turkey.

ORCID-Profile: Cagdas Boyvadoglu, Hasan Ulusal, Seyithan Taysı, Goknur Ozaydin-Yavuz, Ibrahim Halil Yavuz, Pınar Korkmaz, Huseyin Serhat Inaloz

Förderung

  • Gaziantep Üniversitesi

Zitieren

APA

Boyvadoglu, C., Ulusal, H., Taysı, S., Ozaydin-Yavuz, G., Yavuz, I. H., Korkmaz, P., & Inaloz, H. S. (2023). Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria. Mediators of Inflammation, 2023, 1-6. https://doi.org/10.1155/2023/8087274

Vancouver

Boyvadoglu C, Ulusal H, Taysı S, Ozaydin-Yavuz G, Yavuz IH, Korkmaz P, et al. Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria. Mediators of Inflammation. 2023;2023:1-6. doi:10.1155/2023/8087274

BibTeX
@article{Boyvadoglu2023,
  author = {Boyvadoglu, Cagdas and Ulusal, Hasan and Taysı, Seyithan and Ozaydin-Yavuz, Goknur and Yavuz, Ibrahim Halil and Korkmaz, Pınar and Inaloz, Huseyin Serhat},
  title = {Effects of Omalizumab on Serum Levels of Substance P, Calcitonin Gene-Related Peptide, Neuropeptide Y, and Interleukin-31 in Patients with Chronic Spontaneous Urticaria},
  journal = {Mediators of Inflammation},
  year = {2023},
  volume = {2023},
  pages = {1--6},
  doi = {10.1155/2023/8087274}
}
Kostenlos starten →